T. Rowe Price Associates »

Tonix Pharmaceuticals Hldg shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Tonix Pharmaceuticals Hldg (TNXP) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Tonix Pharmaceuticals Hldg

Tip: Access up to 7 years of quarterly data

All positions including Tonix Pharmaceuticals Hldg held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tonix Pharmaceuticals Hldg by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $190k 14k 13.75
2025-12-31 $171k 11k 15.64

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Tonix Pharmaceuticals Hldg

BlackRock
Point72 Asset Management
Millennium Management
AQR Capital Management
Vanguard Capital Management
Jones Hill Capital
Geode Capital Management
Citadel Advisors
UBS Group
State Street Corporation
Susquehanna International
Jane Street
Essex Investment Management
Balyasny Asset Management
Northern Trust

View all funds holding Tonix Pharmaceuticals Hldg